Fluxion Biosciences has teamed up with Bulldog Bio to bring its extensive line of flow cell instrumentation to research labs in the USA and Canada. Bulldog Bio will act as distributor for the BioFlux EZ and BioFlux 200 systems in North America. This exclusive relationship relies upon Bulldog Bio’s marketing expertise, established customer base and desire to closely support technical products in the field.
Ella Fontaine, V.P. of Communications relates, “We are very excited to add a second US-based instrumentation company to our family of partners. We regularly hear from our customers looking for new and innovative products, and Fluxion’s automated flow cell systems will be well received. The BioFlux systems have set a benchmark for biofilm and platelet studies as well as complex cell interactions.” She continues, “It is nice that young technology companies, based here in the US, recognize Bulldog Bio as a leader for marketing, selling and supporting highly technical products to life science researchers.”
The terms of this exclusive distribution contract have not been disclosed.
About Fluxion Biosciences
Fluxion Biosciences provides cellular analysis tools for use in critical life science, drug discovery, and diagnostic applications. Fluxion’s proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Products include the BioFlux™ System for studying cellular interactions, the IonFlux™ System for high throughput patch clamp measurements, and the IsoFlux™ System for circulating tumor cells. Fluxion’s systems are designed to replace laborious and difficult assays by providing intuitive, easy-to-use instruments for cell-based analysis.
Bulldog Bio Incorporated is a privately held company headquartered in Portsmouth, NH, that distributes tools to Life Science researchers.